Stay updated on TRx0237 in Mild-Moderate Alzheimer's Disease Clinical Trial

Sign up to get notified when there's something new on the TRx0237 in Mild-Moderate Alzheimer's Disease Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the TRx0237 in Mild-Moderate Alzheimer's Disease Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov record for the completed Phase 3 TRx0237 study in mild to moderate Alzheimer’s disease is displayed, with details on its study plan, participants, outcomes, and locations.
    Difference
    96%
    Check dated 2026-11-10T13:53:09.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.2 to v3.8.0. The page continues to display a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-11-03T14:58:02.000Z thumbnail image
  3. Check
    25 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov error page’s footer revision changed from v3.7.1 to v3.7.2; the 403 Forbidden message remains.
    Difference
    0.2%
    Check dated 2026-10-20T13:54:34.000Z thumbnail image
  4. Check
    32 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.0 to v3.7.1; the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-13T14:27:18.000Z thumbnail image
  5. Check
    53 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error instead of the study details, indicating access is blocked. The visible content is a generic error page with a Home button, replacing the previously loaded study information.
    Difference
    17%
    Check dated 2026-09-22T22:18:48.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    Revision metadata updated from v3.6.6 to v3.7.0. This indicates a newer version of the study record in the system.
    Difference
    0.0%
    Check dated 2026-09-15T20:51:28.000Z thumbnail image

Stay in the know with updates to TRx0237 in Mild-Moderate Alzheimer's Disease Clinical Trial

Enter your email address, and we'll notify you when there's something new on the TRx0237 in Mild-Moderate Alzheimer's Disease Clinical Trial page.